Big Cypress Acquisition Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Big Cypress Acquisition Corp
TickerSABS
CIK #0001833214
CUSIP78397T202
SectorReal Estate & Construction - Blank Checks
Address300 W 41St Street Suite 202, Miami Beach, FL 33140
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
SAB Biotherapeutics Inc 2025-08-05 175.0 M Exemption: 506(b) · Duration: One year or less · Commission: $10,500,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001833214] 10-K
[0001833214] 10-Q
[0001833214] 3
[0001833214] 4
[0001833214] 5
[0001833214] 8-K
[0001833214] D
[0001833214] SC 13D
[0001833214] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Balyasny Asset Management LP SAB Biotherapeutics Inc [2026-05-15] 0.0
Caligan Partners LP SAB Biotherapeutics Inc [2026-05-15] 0.0
Millennium Management LLC SAB Biotherapeutics Inc [2026-05-01] 0.0
Perceptive Advisors LLC SAB Biotherapeutics Inc [2026-01-22] 0.0
Woodline Partners LP SAB Biotherapeutics Inc [2025-11-14] 0.0
Commodore Capital LP SAB Biotherapeutics Inc [2025-10-03] 0.0
RA Capital Management LP SAB Biotherapeutics Inc [2025-10-03] 0.0
Vivo Opportunity Fund Holdings LP SAB Biotherapeutics Inc [2025-10-03] 0.0
RTW Investments LP SAB Biotherapeutics Inc [2024-02-14] 0.99
Biotechnology Value Fund L P SAB Biotherapeutics Inc [2023-12-04] 5.3
Commodore Capital LP SAB Biotherapeutics Inc [2023-10-16] 0.9
Big Cypress Holdings LLC SAB Biotherapeutics Inc [2021-11-02] 7.0
Sullivan Eddie Joe SAB Biotherapeutics Inc [2021-11-01] 13.12
Hamilton Christine E SAB Biotherapeutics Inc [2021-11-01] 24.58
Radcliffe Capital Management LP Big Cypress Acquisition Corp [2021-10-19] 8.77
Basso Capital Management LP Big Cypress Acquisition Corp [2021-02-24] 5.12
Form 3/4/5 Filer 2011 - 2026
SAB Biotherapeutics Inc
Kropotova Alexandra
to Lucy
Sullivan Eddie Joe
Reich Samuel J
Bausch Christoph Lawrence
Zaccardelli David
Jain Rita
Ellias Helen K
Link David
Giberson Scott
Lucera Erick
Polvino William James
Skyler Jay S
Moin Andrew
Sessa Capital Master LP
Petry John
Sessa Capital IM GP LLC
Sessa Capital IM LP
Sessa Capital GP LLC
Hamilton Christine E
Spragens Jeffrey G
Link David Charles
Conley Mark William
King Michael
Beyer Russell P
Ullerich Melissa Vera
Erickson Bruce Kipp
Finnegan Frederick
Luke Thomas Charles
Pommer Jerry Lynn
Carillo Carlos N
Turner Mervyn
Randall Charles Hiram
Hamilton Edward D
Wu Hua
Katz Ilan
Big Cypress Holdings LLC
Collins Stephen D
Martin James Joseph
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kropotova Alexandra
Common Stock
2026-03-24 Tax withheld 988
Reich Samuel J
Stock option (right to buy) · derivative
2026-02-03 Grant 4,800,000 $0.00
Kropotova Alexandra
Stock option (right to buy) · derivative
2026-02-03 Grant 2,400,000 $0.00
to Lucy
Stock option (right to buy) · derivative
2026-02-03 Grant 2,400,000 $0.00
Sullivan Eddie Joe
Stock option (right to buy) · derivative
2026-02-03 Grant 3,000,000 $0.00
Bausch Christoph Lawrence
Stock option (right to buy) · derivative
2026-02-03 Grant 1,800,000 $0.00
Jain Rita
Stock Option (right to buy) · derivative
2026-01-05 Grant 240,000 $0.00
Zaccardelli David
Stock Option (right to buy) · derivative
2026-01-05 Grant 240,000 $0.00
Polvino William James
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Skyler Jay S
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Lucera Erick
Stock option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Ellias Helen K
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Giberson Scott
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Link David
Stock Option (right to buy) · derivative
2025-12-16 Grant 150,000 $0.00
Kropotova Alexandra
Common Stock
2025-12-11 Tax withheld 988
Moin Andrew
Common Stock
2025-09-29 Option exercise 1,740,000 $1.75 3,045,000
Sessa Capital Master LP +4
Common Stock
2025-09-29 Option exercise 1,740,000 $1.75 3,045,000
Moin Andrew
Series B Convertible Preferred Stock · derivative
2025-09-29 Option exercise 17,400
Sessa Capital Master LP +4
Series B Convertible Preferred Stock · derivative
2025-09-29 Option exercise 17,400
Common Stock
2025-09-19 Tax withheld 1,977
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 79 69,764,794
2025-12-31 48 36,342,111
2025-09-30 34 28,024,025
2025-06-30 26 1,923,784
2025-03-31 27 2,209,552
2024-12-31 26 2,633,099
2024-09-30 26 3,141,852
2024-06-30 23 3,127,263
2024-03-31 25 3,342,174
2023-12-31 43 34,795,639
2023-09-30 35 3,016,240
2023-06-30 39 3,150,975
Form 13F Holdings
Firm Period DFND Voting Shares
Simplify Asset Management Inc [2026-06-30] SOLE 104,849 104,849
IFP Advisors LLC [2026-06-30] SOLE 38,699 38,699
First PREMIER Bank [2026-06-30] SOLE 18,986 18,986
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com